http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SV-2012004361-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6572ff5df928fd17340eb2a8cb6d8502
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-403
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
filingDate 2012-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc8a334cbee6295be93c268f1a754684
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc5fdb123bea635f522746d59b87354b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3333b346a6a1d49d19d6f6de8263933
publicationDate 2015-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber SV-2012004361-A
titleOfInvention NEW ASSOCIATION BETWEEN 4- {3- [CIS-HEXAHYDROCICLOPENTA [C] PIRROL-2 (1H) -IL] PROPOXI} BENZAMIDA AND AN ANTAGONIST OF NMDA RECEPTORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
abstract ASSOCIATION BETWEEN 4- {3- [CIS-HEXAHYDROCICLOPENTA [C] PIRROL-2 (1H) -IL] PROPOXI} FORMULA BENZAMIDE (I): (SEE FORMULA); OR ONE OF ITS SALTS OF ADDITION TO AN ACID OR TO A PHARMACEUTICALLY ACCEPTABLE BASE, AND AN ANTAGONIST OF NMDA GLUTAMATERIC RECEIVERS
priorityDate 2011-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22880
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557010
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558257
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID611
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2331
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557728

Total number of triples: 21.